UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Buys 37,468 Shares of Sotera Health (NASDAQ:SHC)

UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC grew its position in Sotera Health (NASDAQ:SHC - Free Report) by 14.3% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 299,463 shares of the company's stock after purchasing an additional 37,468 shares during the period. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC owned about 0.11% of Sotera Health worth $4,097,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Blue Trust Inc. raised its holdings in shares of Sotera Health by 164.3% during the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after purchasing an additional 1,140 shares in the last quarter. Quarry LP acquired a new position in Sotera Health during the fourth quarter worth $28,000. Tower Research Capital LLC TRC raised its holdings in Sotera Health by 37.8% during the fourth quarter. Tower Research Capital LLC TRC now owns 5,975 shares of the company's stock valued at $82,000 after buying an additional 1,640 shares in the last quarter. Sterling Capital Management LLC raised its holdings in Sotera Health by 58.5% during the fourth quarter. Sterling Capital Management LLC now owns 9,029 shares of the company's stock valued at $124,000 after buying an additional 3,331 shares in the last quarter. Finally, PNC Financial Services Group Inc. lifted its position in shares of Sotera Health by 39.4% in the fourth quarter. PNC Financial Services Group Inc. now owns 9,302 shares of the company's stock worth $127,000 after buying an additional 2,627 shares during the last quarter. 91.03% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on SHC. Barclays lowered their price objective on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. Wall Street Zen cut Sotera Health from a "buy" rating to a "hold" rating in a research report on Saturday. Piper Sandler lowered their price target on Sotera Health from $15.00 to $13.00 and set a "neutral" rating on the stock in a report on Wednesday, April 23rd. Finally, The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and boosted their price objective for the stock from $14.00 to $17.00 in a research note on Monday, May 5th. Two research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. According to data from MarketBeat.com, Sotera Health presently has a consensus rating of "Moderate Buy" and an average target price of $15.80.

Sotera Health Stock Performance

Shares of NASDAQ SHC traded up $0.11 during trading hours on Friday, hitting $12.30. 2,562,971 shares of the company's stock were exchanged, compared to its average volume of 1,207,190. Sotera Health has a 1-year low of $9.53 and a 1-year high of $17.08. The company has a debt-to-equity ratio of 4.91, a current ratio of 2.88 and a quick ratio of 2.61. The stock has a market capitalization of $3.49 billion, a price-to-earnings ratio of 49.20 and a beta of 1.87. The company's 50-day moving average price is $11.74 and its 200-day moving average price is $12.55.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its earnings results on Thursday, May 1st. The company reported $0.14 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.12 by $0.02. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm had revenue of $254.52 million for the quarter, compared to analyst estimates of $245.56 million. During the same quarter last year, the firm posted $0.13 EPS. The company's revenue was up 2.6% on a year-over-year basis. On average, sell-side analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.